Impact of variable RBE on proton fractionation

Medical Physics

Volumn 40, Issue 1, 2013, Pages

  Dasu, Alexandru ^a,b   Toma Dasu, Iuliana ^c  

^a Department of Clinical Immunology and Transfusion Medicine   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

fractionation; LQ model; proton radiotherapy; RBE

Indexed keywords

ENERGY TRANSFER; FRACTIONATION; HISTOLOGY; RADIOTHERAPY; TUMORS;

ANALYTICAL EXPRESSIONS; DOSE FRACTIONATION; FRACTIONATION PATTERNS; LINEAR ENERGY TRANSFER; LINEAR-QUADRATIC MODELS; PROTON RADIOTHERAPY; RADIOBIOLOGICAL EFFECTIVENESS; RELATIVE BIOLOGICAL EFFECTIVENESS;

PROTON BEAM THERAPY;

PROTON;

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; LINEAR ENERGY TRANSFER; MALE; PRIORITY JOURNAL; PROSTATE TUMOR; PROTON THERAPY; RADIATION DOSE FRACTIONATION; RELATIVE BIOLOGIC EFFECTIVENESS; PROBABILITY; STATISTICAL MODEL;

DOSE FRACTIONATION; HUMANS; LINEAR ENERGY TRANSFER; MALE; MODELS, STATISTICAL; PROBABILITY; PROSTATIC NEOPLASMS; PROTONS; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 84872046853     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.4769417     Document Type: Article

References (37)

1. H. Suit, T. DeLaney, S. Goldberg, H. Paganetti, B. Clasie, L. Gerweck, A. Niemierko, E. Hall, J. Flanz, J. Hallman, and A. Trofimov, " Proton vs carbon ion beams in the definitive radiation treatment of cancer patients.," Radiother. Oncol. 95, 3-22 (2010). 10.1016/j.radonc.2010.01.015
2. ICRU, " Prescribing, recording, and reporting proton-beam therapy.," ICRU Report 78, Journal of the ICRU, Vol. 7, No. 2, International Commission on Radiation Units and Measurements, Bethesda, 2007.
3. L. E. Gerweck and S. V. Kozin, " Relative biological effectiveness of proton beams in clinical therapy.," Radiother. Oncol. 50, 135-142 (1999). 10.1016/S0167-8140(98)00092-9 (Pubitemid 29155537)
4. N. Tilly, J. Johansson, U. Isacsson, J. Medin, E. Blomquist, E. Grusell, and B. Glimelius, " The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer.," Phys. Med. Biol. 50, 2765-2777 (2005). 10.1088/0031-9155/50/12/003 (Pubitemid 40771010)
5. A. Carabe, M. Moteabbed, N. Depauw, J. Schuemann, and H. Paganetti, " Range uncertainty in proton therapy due to variable biological effectiveness.," Phys. Med. Biol. 57, 1159-1172 (2012). 10.1088/0031-9155/57/5/1159
6. M. C. Frese, J. J. Wilkens, P. E. Huber, A. D. Jensen, U. Oelfke, and Z. Taheri-Kadkhoda, " Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy.," Int. J. Radiat. Oncol., Biol., Phys. 79, 80-88 (2011). 10.1016/j.ijrobp.2009.10.022
7. J. B. Robertson, J. R. Williams, R. A. Schmidt, J. B. Little, D. F. Flynn, and H. D. Suit, " Radiobiological studies of a high-energy modulated proton beam utilizing cultured mammalian cells.," Cancer 35, 1664-1677 (1975). 10.1002/1097-0142(197506)35:6<1664::AID-CNCR2820350628>3.0.CO;2- %23
8. H. Paganetti, P. Olko, H. Kobus, R. Becker, T. Schmitz, M. P. Waligorski, D. Filges, and H. W. Muller-Gartner, " Calculation of relative biological effectiveness for proton beams using biological weighting functions.," Int. J. Radiat. Oncol., Biol., Phys. 37, 719-729 (1997). 10.1016/S0360-3016(96) 00540-8 (Pubitemid 27175328)
9. J. F. Fowler and B. E. Stern, " Dose-rate effects: Some theoretical and practical considerations.," Br. J. Radiol. 33, 389-395 (1960). 10.1259/0007-1285-33-390-389
10. K. H. Chadwick and H. P. Leenhouts, " A molecular theory of cell survival.," Phys. Med. Biol. 18, 78-87 (1973). 10.1088/0031-9155/18/1/007
11. G. W. Barendsen, " Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.," Int. J. Radiat. Oncol., Biol., Phys. 8, 1981-1997 (1982). 10.1016/0360-3016(82)90459-X (Pubitemid 13167385)
12. J. F. Fowler, " The linear-quadratic formula and progress in fractionated radiotherapy.," Br. J. Radiol. 62, 679-694 (1989). 10.1259/0007-1285-62-740-679 (Pubitemid 19194494)
13. D. J. Brenner, " The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.," Semin. Radiat. Oncol. 18, 234-239 (2008). 10.1016/j.semradonc. 2008.04.004
14. A. Dasu and I. Toma-Dasu, " What is the clinically relevant relative biologic effectiveness A warning for fractionated treatments with high linear energy transfer radiation.," Int. J. Radiat. Oncol., Biol., Phys. 70, 867-874 (2008). 10.1016/j.ijrobp.2007.07.2358 (Pubitemid 351199715)
15. R. B. Hawkins, " A statistical theory of cell killing by radiation of varying linear energy transfer.," Radiat. Res. 140, 366-374 (1994). 10.2307/3579114 (Pubitemid 24381484)
16. R. B. Hawkins, " A microdosimetric-kinetic theory of the dependence of the RBE for cell death on LET.," Med. Phys. 25, 1157-1170 (1998). 10.1118/1.598307 (Pubitemid 28335268)
17. R. G. Dale and B. Jones, " The assessment of RBE effects using the concept of biologically effective dose.," Int. J. Radiat. Oncol., Biol., Phys. 43, 639-645 (1999). 10.1016/S0360-3016(98)00364-2 (Pubitemid 29107189)
18. J. J. Wilkens and U. Oelfke, " A phenomenological model for the relative biological effectiveness in therapeutic proton beams.," Phys. Med. Biol. 49, 2811-2825 (2004). 10.1088/0031-9155/49/13/004 (Pubitemid 39004134)
19. A. Carabe-Fernandez, R. G. Dale, J. W. Hopewell, B. Jones, and H. Paganetti, " Fractionation effects in particle radiotherapy: Implications for hypo-fractionation regimes.," Phys. Med. Biol. 55, 5685-5700 (2010). 10.1088/0031-9155/55/19/005
20. M. Wedenberg, B. K. Lind, and B. Hardemark, " A model for the relative biological effectiveness of protons: The tissue specific parameter alpha/beta of photons is a predictor for the sensitivity to LET changes.," Acta Oncol. (2012) [E-pub ahead of print]. 10.3109/0284186X.2012.705892
21. A. M. Kellerer and H. H. Rossi, " The theory of dual radiation action.," Curr. Top. Radiat. Res. Q 8, 85-158 (1972).
22. C. Grassberger, A. Trofimov, A. Lomax, and H. Paganetti, " Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning.," Int. J. Radiat. Oncol., Biol., Phys. 80, 1559-1566 (2011). 10.1016/j.ijrobp.2010.10.027
23. C. Grassberger and H. Paganetti, " Elevated LET components in clinical proton beams.," Phys. Med. Biol. 56, 6677-6691 (2011). 10.1088/0031-9155/56/20/011
24. I. Kantemiris, P. Karaiskos, P. Papagiannis, and A. Angelopoulos, " Dose and dose averaged LET comparison of 1H, 4He, 6Li, 8Be, 10B, 12C, 14N, and 16O ion beams forming a spread-out Bragg peak.," Med. Phys. 38, 6585-6591 (2011). 10.1118/1.3662911
25. J. Yang, J. F. Fowler, J. P. Lamond, R. Lanciano, J. Feng, and L. W. Brady, " Red shell: Defining a high-risk zone of normal tissue damage in stereotactic body radiation therapy.," Int. J. Radiat. Oncol., Biol., Phys. 77, 903-909 (2010). 10.1016/j.ijrobp.2009.12.069
26. J. D. Slater, C. J. Rossi Jr., L. T. Yonemoto, D. A. Bush, B. R. Jabola, R. P. Levy, R. I. Grove, W. Preston, and J. M. Slater, " Proton therapy for prostate cancer: The initial Loma Linda University experience.," Int. J. Radiat. Oncol., Biol., Phys. 59, 348-352 (2004). 10.1016/j.ijrobp.2003.10.011 (Pubitemid 38622585)
27. A. L. Zietman, M. L. DeSilvio, J. D. Slater, C. J. Rossi Jr., D. W. Miller, J. A. Adams, and W. U. Shipley, " Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial.," J. Am. Med. Assoc. 294, 1233-1239 (2005). 10.1001/jama.294.10.1233 (Pubitemid 41352111)
28. H. D. Thames, D. Kuban, L. B. Levy, E. M. Horwitz, P. Kupelian, A. Martinez, J. Michalski, T. Pisansky, H. Sandler, W. Shipley, M. Zelefsky, and A. Zietman, " The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995.," Radiother. Oncol. 96, 6-12 (2010). 10.1016/j.radonc.2010.03.020
29. A. Dasu and I. Toma-Dasu, " Prostate alpha/beta revisited-An analysis of clinical results from 14168 patients.," Acta Oncol. 51, 963-974 (2012). 10.3109/0284186X.2012.719635
30. A. Dasu, " Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials," Clin. Oncol. 19, 289-301 (2007). 10.1016/j.clon.2007.02.007 (Pubitemid 46760594)
31. A. Dasu, " Radiobiology of prostate cancer.," in Robotic Radiosurgery. Treating Prostate Cancer and Related Genitourinary Applications, edited by, L. E. Ponsky, D. B. Fuller, R. M. Meier, and, C.-M. C. Ma, (Springer, Berlin, 2012), pp. 79-101. 10.1007/978-3-642-11495-3-8
32. S. Koike, K. Ando, C. Oohira, T. Fukawa, R. Lee, N. Takai, M. Monobe, Y. Furusawa, M. Aoki, S. Yamada, W. Shimizu, K. Nojima, and H. Majima, " Relative biological effectiveness of 290 MeV/u carbon ions for the growth delay of a radioresistant murine fibrosarcoma.," J. Radiat. Res. 43, 247-255 (2002). 10.1269/jrr.43.247 (Pubitemid 135691179)
33. R. B. Hawkins, " A microdosimetric-kinetic model for the effect of non-Poisson distribution of lethal lesions on the variation of RBE with LET.," Radiat. Res. 160, 61-69 (2003). 10.1667/RR3010 (Pubitemid 36828614)
34. M. Wedenberg, B. K. Lind, I. Toma-Dasu, H. Rehbinder, and A. Brahme, " Analytical description of the LET dependence of cell survival using the repairable-conditionally repairable damage model.," Radiat. Res. 174, 517-525 (2010). 10.1667/RR2045.1
35. L. Antonovic, A. Brahme, Y. Furusawa, and I. Toma-Dasu, " Radiobiological description of the LET dependence of the cell survival of oxic and anoxic cells irradiated by carbon ions.," J. Radiat. Res. (2012) [E-pub ahead of print]. 10.1093/jrr/rrs070
36. E. J. Hall and A. J. Giaccia, Radiobiology for the Radiologist, 6th ed. (Lippincott/Williams Wilkins, Philadelphia, 2006).
37. K. Wiklund, I. Toma-Dasu, and B. K. Lind, " The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy.," Phys. Med. Biol. 56, 7585-7600 (2011). 10.1088/0031-9155/56/23/ 016